As AstraZeneca works to incorporate Alexion following its major buyout, the company is already breaking out its checkbook to invest in next-gen manufacturing capacity. On Tuesday, the U.K ...

AstraZeneca PLC said Tuesday that it will invest $360 million in a manufacturing facility in Ireland. The pharmaceutical company said it is planning to build an active pharmaceutical ingredient ...

AstraZeneca said on Tuesday it would invest $360 million to develop a manufacturing facility in Ireland to produce active pharmaceutical ingredients (APIs), or the main components of medicines.

Anglo-Swedish group AstraZeneca plans to have its first manufacturing base in Ireland operational in Dublin by 2025 in a further boost to the country’s life sciences sector.. Companies like ...

AstraZeneca’s chief executive said the U.K.’s “discouraging” tax rate was behind the company’s decision to build a $400 million API facility at the former Alexion campus in Dublin.

AstraZeneca unveiled plans for the Dublin facility in September 2021 with what was then a €337M price tag for construction of an API facility for small molecules.